Ex vivo study of transdermal permeation of four diclofenac salts from different vehicles

Journal of Pharmaceutical Sciences

Volumn 96, Issue 4, 2007, Pages 814-823

  Minghetti, Paola ^a   Cilurzo, Francesco ^a   Casiraghi, Antonella ^a   Montanari, Luisa ^a   Fini, Adamo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Counterions; Diclofenac salts; Permeability coefficient; Permeation enhancer vehicles; Solubility; Transdermal permeation

Indexed keywords

DICLOFENAC; DICLOFENAC DIETHYLAMINE; DICLOFENAC POTASSIUM; DIETHYLAMINE; DIETHYLENE GLYCOL MONOETHYL ETHER; EPOLAMINE; OLEIC ACID; POTASSIUM; PROPYLENE GLYCOL; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG SOLUBILITY; EPIDERMIS; EX VIVO STUDY; HUMAN; HUMAN CELL; SKIN PENETRATION; STRATUM CORNEUM;

EID: 34247480143     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20770     Document Type: Article

References (34)

1. Cordero JA, Alarcon L, Escribano E, Obach R, Domenech J. 1997. A comparative study of the transdermal penetration of a series of non steroidal anti-inflammatory drugs. J Pharm Sci 86:503-508.
2. Fini A, Fazio G, González-Rodriguez M, Cavallari C, Passerini N, Rodriguez L. 1999. Formation of ion-pairs in aqueous solutions of diclofenac salts. Int J Pharm 187:163-173.
3. Fini A, Feroci G, Fazio G, Fernandez-Hervas MJ, Holgado MA, Rabasco AM. 1996. Effects of the counterions on the properties of diclofenac salts. Int J Pharm Adv 1:269-284.
4. O'Connor KM, Corrigan OI. 2001. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. Int J Pharm 222:281-293.
5. Devi K, Paranjothy KL. 1999. Pharmacokinetic profile of a new matrix-type transdermal delivery system: Diclofenac diethyl ammonium patch. Drug Dev Ind Pharm 25:695-700.
6. Arora P, Mukherjee BB. 2002. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci 91:2076-2089.
7. Fang JY, Wang RJ, Huang YB, Wu PC, Tsai YH. 2001. Influence of electrical and chemical factors on transdermal iontophoretic delivery of three diclofenac salts. Biol Pharm Bull 24:390-394.
8. Vincent C-M, Laugel C, Marty J-P. 1999. In vitro topical delivery of non-steroidal anti-inflammatory drugs through human skin. Arzneim-Forsch/Drug Res 49:509-513.
9. Rana V, Rai P, Tiwary AK, Gupta S. 1999. Enhanced in vitro percutaneous permeation of diclofenac sodium with primary amine and pyrrolidone ion-pairs. Indian Drugs 36:21-28.
10. Hadgraft J, Valenta C. 2000. pH, pKa and dermal delivery. Int J Pharm 200:243-247.
11. Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv Rev 56:603-618.
12. Hadgraft J, Lane ME. 2005. Skin permeation: The years of enlightenment. Int J Pharm 305:2-12.
13. Swart H, Breytenbach JC, Hadgraft J, DuPlessis J. 2005. Synthesis and transdermal penetration of NSAID glycoside esters. Int J Pharm 301:71-79.
14. Fourie L, Breytenbach JC, DuPlessis J, Goosen C, Swart H, Hadgraft J. 2004. Percutaneous delivery of carbamazepine and selected N-alkyl and N-hydroxyalkyl analogues. Int J Pharm 279:59-66.
15. Barry BW. 2001. Novel mechanism and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101-114.
16. Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A. 2004. The effect of penetration enhancers on drug delivery through skin: A QSAR study. J Control Release 99:113-125.
17. Fang JY, Hwang TL, Fang CL, Chiu HC. 2003. In vitro and in vivo evaluation of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 255:153-166.
18. Moser K, Kriwet K, Kalia YN, Guy RH. 2001. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery. Int J Pharm 224:169-176.
19. Moser K, Kriwet K, Kalia YN, Guy RH. 2001. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J Control Release 73:245-253.
20. Fini A, Fazio G, Rapaport I, Rabasco AM. 1994. Comportamento in soluzione di alcuni sali del diclofenac. Acta Technol Leg Med V:13-28.
21. Maitani Y, Coutel-Egros A, Obata Y, Nagai T. 1993. Prediction of skin permeability of diclofenac and propranolol from theoretical partition coefficients determined from cohesion parameters. J Pharm Sci 82:416-420.
22. Bustamante P, Pena MA, Barra J. 1998. Partial-solubility parameters of naproxen and sodium diclofenac. Pharm Pharmacol 50:975-982.
23. Fang JY, Hwang TL, Leu YL. 2003. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int J Pharm 250:313-325.
24. Al-Saidan SM. 2004. Transdermal self-permeation enhancement of ibuprofen. J Control Release 100:199-209.
25. Roy SD, Manoukian E. 1995. Transdermal delivery of ketorolac tromethamine: Permeation enhancement, device design, and pharmacokinetics in healthy humans. J Pharm Sci 84:1190-1196.
26. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. 2001. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52:103-112.
27. Okumura M, Sugibayashi K, Ogawa K, Morimoto Y. 1989. Skin permeability of water soluble drugs. Chem Pharm Bull (Tokio) 37:1404-1406.
28. Fini A, Garuti M, Fazio G, Alvarez-Fuentes J, Holgado MA. 2001. Diclofenac Salts. I. Fractal and thermal analysis of sodium and potassium diclofenac salts. J Pharm Sci 90:2049-2057.
29. Fini A, Fazio G, Rosetti F, Holgado MA, Iruín A, Alvarez-Fuentes J. 2005. Diclofenac salts, III. Alkaline and earth alkaline salts. J Pharm Sci 32:53-61.
30. 2O). Acta Crystallogr C 57:437-438.
31. Ledwidge MT, Draper SM, Wilcock DJ, Corrigan OI. 1996. Physicochemical characterization of diclofenac N-(2-hydroxyethyl) pyrrolidine: Anhydrate and dihydrate crystalline forms. J Pharm Sci 85:16-21.
32. Fini A, Fazio G, Feroci G. 1995. Solubility and solubilization of non steroidal anti-inflammatory drugs. Int J Pharm 126:95-102.
33. Cilurzo F, Minghetti P, Casiraghi A, Tosi L, Pagani S, Montanari L. 2005. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen. Eur J Pharm Biopharm 60:61-66.
34. Bergonzi MC, Bilia AR, Casiraghi A, Cilurzo F, Minghetti P, Montanari L, Vincieri FF. 2005. Evaluation of skin permeability of sesquiterpenes of an innovative supercritical carbon dioxide Arnica extract by HPLC/DAD/MS. Pharmazie 60:36-38.